Vectofusin-1 Improves Transduction of Primary Human Cells with Diverse Retroviral and Lentiviral Pseudotypes, Enabling Robust, Automated Closed-System Manufacturing

DOI Web Site Web Site 1 Citations

Constanze Radek

Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany.
Ornellie Bernadin

CIRI—International Center for Infectiology Research, Team EVIR, Université de Lyon, Lyon, France.
Katharina Drechsel

Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany.
Nicole Cordes

Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany.
Rita Pfeifer

Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany.
Pia Sträßer

Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany.
Mirella Mormin

Integrare Research Unit UMR_S951, Genethon, INSERM, University Evry, EPHE, Evry, France.
Alejandra Gutierrez-Guerrero

CIRI—International Center for Infectiology Research, Team EVIR, Université de Lyon, Lyon, France.
François-loïc Cosset

CIRI—International Center for Infectiology Research, Team EVIR, Université de Lyon, Lyon, France.
Andrew D. Kaiser

Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany.
Thomas Schaser

Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany.
Anne Galy

Integrare Research Unit UMR_S951, Genethon, INSERM, University Evry, EPHE, Evry, France.
Els Verhoeyen

CIRI—International Center for Infectiology Research, Team EVIR, Université de Lyon, Lyon, France.
Ian C.D. Johnston

Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany.

Journal

Human Gene Therapy

Human Gene Therapy 30 (12), 1477-1493, 2019-12-01

Mary Ann Liebert Inc

Back to top